These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9738873)
1. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Martiniuk F; Chen A; Mack A; Arvanitopoulos E; Chen Y; Rom WN; Codd WJ; Hanna B; Alcabes P; Raben N; Plotz P Am J Med Genet; 1998 Aug; 79(1):69-72. PubMed ID: 9738873 [No Abstract] [Full Text] [Related]
2. Increased urinary excretion of a glycogen-derived tetrasaccharide in heterozygotes with glycogen storage diseases type II and III. Chester MA; Lundblad A; Häger A; Sjöblad S; Loonen C; Tager JM; Zopf D Lancet; 1983 Apr; 1(8331):994-5. PubMed ID: 6132305 [No Abstract] [Full Text] [Related]
3. Glycogen storage disease in Israel. A clinical, biochemical and genetic study. Levin S; Moses SW; Chayoth R; Jagoda N; Steinitz K Isr J Med Sci; 1967; 3(3):397-410. PubMed ID: 5317551 [No Abstract] [Full Text] [Related]
4. Glycogen storage disease type II in Spanish patients: high frequency of c.1076-1G>C mutation. Gort L; Coll MJ; Chabás A Mol Genet Metab; 2007; 92(1-2):183-7. PubMed ID: 17616415 [TBL] [Abstract][Full Text] [Related]
5. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. Chamoles NA; Niizawa G; Blanco M; Gaggioli D; Casentini C Clin Chim Acta; 2004 Sep; 347(1-2):97-102. PubMed ID: 15313146 [TBL] [Abstract][Full Text] [Related]
6. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Ausems MG; Verbiest J; Hermans MP; Kroos MA; Beemer FA; Wokke JH; Sandkuijl LA; Reuser AJ; van der Ploeg AT Eur J Hum Genet; 1999 Sep; 7(6):713-6. PubMed ID: 10482961 [TBL] [Abstract][Full Text] [Related]
7. Severe Cardiac Involvement Is Rare in Patients with Late-Onset Pompe Disease and the Common c.-32-13T>G Variant: Implications for Newborn Screening. Herbert M; Cope H; Li JS; Kishnani PS J Pediatr; 2018 Jul; 198():308-312. PubMed ID: 29627187 [TBL] [Abstract][Full Text] [Related]
8. Two clinical forms of glycogen-storage disease type II in two generations of the same family. Amartino H; Painceira D; Pomponio RJ; Niizawa G; Sabio Paz V; Blanco M; Chamoles N Clin Genet; 2006 Feb; 69(2):187-8. PubMed ID: 16433701 [No Abstract] [Full Text] [Related]
9. Outcome of the treatment of glycogen storage disease. Fernandes J; Smit GP; Berger R Acta Paediatr Jpn; 1988 Aug; 30(4):457-61. PubMed ID: 3150236 [No Abstract] [Full Text] [Related]
10. A family with different clinical forms of acid maltase deficiency (glycogenosis type II): biochemical and genetic studies. Loonen MC; Busch HF; Koster JF; Martin JJ; Niermeijer MF; Schram AW; Brouwer-Kelder B; Mekes W; Slee RG; Tager JM Neurology; 1981 Oct; 31(10):1209-16. PubMed ID: 6810200 [TBL] [Abstract][Full Text] [Related]
11. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease. Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108 [TBL] [Abstract][Full Text] [Related]
12. A novel acid alpha-glucosidase mutation identified in a Pakistani family with glycogen storage disease type II. Kroos MA; Waitfield AE; Joosse M; Winchester B; Reuser AJ; MacDermot KD J Inherit Metab Dis; 1997 Aug; 20(4):556-8. PubMed ID: 9266392 [TBL] [Abstract][Full Text] [Related]
13. Detection of a novel mutation in the GAA gene in an Iranian child with glycogen storage disease type II. Galehdari H; Emami M; Mohammadian G; Khodadadi A; Azmoon S; Baradaran M Arch Iran Med; 2013 Feb; 16(2):126-8. PubMed ID: 23360637 [TBL] [Abstract][Full Text] [Related]
14. Glycogenosis type II: the infantile- and late-onset acid maltase deficiency observed in one family. Koster JF; Busch HF; Slee RG; Van Weerden TW Clin Chim Acta; 1978 Aug; 87(3):451-3. PubMed ID: 28188 [TBL] [Abstract][Full Text] [Related]
15. Late-onset acid maltase deficiency. Detection of patients and heterozygotes by urinary enzyme assay. Mehler M; DiMauro S Arch Neurol; 1976 Oct; 33(10):692-5. PubMed ID: 9923 [TBL] [Abstract][Full Text] [Related]
16. Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. Kroos MA; Van der Kraan M; Van Diggelen OP; Kleijer WJ; Reuser AJ; Van den Boogaard MJ; Ausems MG; Ploos van Amstel HK; Poenaru L; Nicolino M J Med Genet; 1995 Oct; 32(10):836-7. PubMed ID: 8558570 [No Abstract] [Full Text] [Related]
17. [Tests for the detection of inborn errors of metabolism--urinary alpha-glucosidase analysis for the detection of glycogen storage disease type II (author's transl)]. Soyama K; Ono E Rinsho Byori; 1978 Dec; 26(12):1022-6. PubMed ID: 370427 [No Abstract] [Full Text] [Related]
18. Two novel mutations in the gene that codes for acid α-glucosidase in a baby with Pompe disease. Hu J; Sun L; Ren W; Xu M Eur Heart J; 2015 Apr; 36(14):883. PubMed ID: 25612604 [No Abstract] [Full Text] [Related]
19. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease]. Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935 [TBL] [Abstract][Full Text] [Related]
20. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases. Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]